An official website of the United States government

Here's how you know

Official websites use .mil

A .mil website belongs to an official U.S. Department of Defense organization in the United States.

Secure .mil websites use HTTPS

A lock () or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

JPEO-CBRND Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense

JPEO-CBRND

Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):

NEWS & MEDIA

Stay Connected with Social Media

JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office below.

JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as our – Command Brief, the Chemical Biological Defense Program's Enterprise Strategy, leadership biographies, COVID-19 fact sheets, and contracting overview documents.

Download Press Kit

JPEO-CBRND News

Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

PHOTO INFORMATION

Download

Details

201116-A-HZ730-1019

Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics. (U.S. Army photo by Jason W. Edwards)

On July 28, 2022, the Department of Defense (DoD), on behalf of and in coordination with the U.S. Department of Health and Human Services (HHS), awarded a $1.74 billion agreement to purchase over 65 million doses of Moderna’s COVID-19 vaccine for a fall vaccination campaign. The vaccine will target the SARS-CoV-2 Omicron subvariant viruses, as recommended by the U.S. Food and Drug Administration (FDA).

This purchase is in addition to the 105 million COVID-19 vaccine doses the U.S. Government recently purchased from Pfizer for the fall vaccination campaign. Combined, the two agreements provide over 170 million mRNA vaccine booster doses for adults and children this fall, with options to procure up to 600 million doses if needed to meet demand. With FDA authorization of the vaccine and a recommendation by the Centers for Disease Control and Prevention, HHS will receive the first deliveries of the vaccine in early fall.

The DoD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) led this effort in partnership with DoD’s Defense Assisted Acquisition Cell (DA2), U.S. Army Contracting Command, and HHS’s Biomedical Advanced Research and Development Authority (BARDA).

###

In alignment with Department of Defense (DoD) Instruction 5400.17 and recent Executive Orders issued by the President, the U.S. Army has reviewed and adjusted its social media content to ensure compliance with DoD policies and priorities. As a result, certain posts have been removed, are in a process of being removed or modified to maintain consistency with federal guidance and uphold the integrity of our official communication channels. Content will be archived in accordance with DA PAM 25–403.

The U.S. Army remains committed to transparency, professionalism, and adherence to DoD directives while continuing to engage with our community in a manner that reflects our core values.

For any questions regarding social media policies, please refer to official DoD guidance available at https://www.esd.whs.mil/Directives/issuances/dodi/.